Quantitative analysis of wild-type and precore mutant hepatitis B virus in carriers

Hirofumi Tsugeno, Gotaro Yamada, Moritoshi Kinoshita, Hiroyuki Shimomura, Yoshiaki Iwasaki, Takao Tsuji

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

In the present study, we have analyzed the amount of precore wild-type hepatitis B virus (HBV) (wild-type) and precore mutant HBV (nt 1896: G → A) (precore mutant) of HBV carriers; 31 asymptomatic healthy carriers (ASC) and 28 patients with chronic hepatitis (CH). Wild-type and precore mutant were quantified using sensitive and specific quantification methods: competitive wild-type-sequence-specific assay and competitive mutation-site-specific assay with different sets of specific primers and internal controls. Median serum levels of wild-type and precore mutant were 9.60 and 8.60 log copies/ml (median percentages of precore mutant in total HBV-DNA: 11.7%) in HBeAg(+) ASC, 8.48 and 8.00 (33.3%) in HBeAg(+) CH, and 6.30 and 6.85 (84.71%) in anti-HBe(+) CH, respectively, showing higher levels of the relative amount of precore mutant to wild-type along with HBeAg/anti-HBe status. Only precore mutant, but not wild-type was detected in anti-HBe(+) ASC. Although median percentages of precore mutant at the anti-HBe(+) ASC and CH stages were much higher than those at the HBeAg(+) ASC and CH stages, a substantial amount of precore mutant was found even at the HBeAg(+) stages. Existence of a substantial amount of precore mutant even in HBeAg(+) ASC suggests that the occurrence of precore mutant is not always closely associated with seroconversion from HBeAg to anti-HBe.

Original languageEnglish
Pages (from-to)48-54
Number of pages7
JournalHepatology Research
Volume23
Issue number1
DOIs
Publication statusPublished - May 1 2002

Fingerprint

Hepatitis B e Antigens
Hepatitis B virus
Chronic Hepatitis
Mutation
DNA
Serum

Keywords

  • Asymptomatic healthy carrier
  • Chronic hepatitis B
  • Competitive mutation-site-specific assay
  • Competitive wild-type-sequence-specific assay
  • Polymerase chain reaction

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Quantitative analysis of wild-type and precore mutant hepatitis B virus in carriers. / Tsugeno, Hirofumi; Yamada, Gotaro; Kinoshita, Moritoshi; Shimomura, Hiroyuki; Iwasaki, Yoshiaki; Tsuji, Takao.

In: Hepatology Research, Vol. 23, No. 1, 01.05.2002, p. 48-54.

Research output: Contribution to journalArticle

Tsugeno, Hirofumi ; Yamada, Gotaro ; Kinoshita, Moritoshi ; Shimomura, Hiroyuki ; Iwasaki, Yoshiaki ; Tsuji, Takao. / Quantitative analysis of wild-type and precore mutant hepatitis B virus in carriers. In: Hepatology Research. 2002 ; Vol. 23, No. 1. pp. 48-54.
@article{c0a81dd130064fad826c8f23d7b3cf36,
title = "Quantitative analysis of wild-type and precore mutant hepatitis B virus in carriers",
abstract = "In the present study, we have analyzed the amount of precore wild-type hepatitis B virus (HBV) (wild-type) and precore mutant HBV (nt 1896: G → A) (precore mutant) of HBV carriers; 31 asymptomatic healthy carriers (ASC) and 28 patients with chronic hepatitis (CH). Wild-type and precore mutant were quantified using sensitive and specific quantification methods: competitive wild-type-sequence-specific assay and competitive mutation-site-specific assay with different sets of specific primers and internal controls. Median serum levels of wild-type and precore mutant were 9.60 and 8.60 log copies/ml (median percentages of precore mutant in total HBV-DNA: 11.7{\%}) in HBeAg(+) ASC, 8.48 and 8.00 (33.3{\%}) in HBeAg(+) CH, and 6.30 and 6.85 (84.71{\%}) in anti-HBe(+) CH, respectively, showing higher levels of the relative amount of precore mutant to wild-type along with HBeAg/anti-HBe status. Only precore mutant, but not wild-type was detected in anti-HBe(+) ASC. Although median percentages of precore mutant at the anti-HBe(+) ASC and CH stages were much higher than those at the HBeAg(+) ASC and CH stages, a substantial amount of precore mutant was found even at the HBeAg(+) stages. Existence of a substantial amount of precore mutant even in HBeAg(+) ASC suggests that the occurrence of precore mutant is not always closely associated with seroconversion from HBeAg to anti-HBe.",
keywords = "Asymptomatic healthy carrier, Chronic hepatitis B, Competitive mutation-site-specific assay, Competitive wild-type-sequence-specific assay, Polymerase chain reaction",
author = "Hirofumi Tsugeno and Gotaro Yamada and Moritoshi Kinoshita and Hiroyuki Shimomura and Yoshiaki Iwasaki and Takao Tsuji",
year = "2002",
month = "5",
day = "1",
doi = "10.1016/S1386-6346(01)00156-5",
language = "English",
volume = "23",
pages = "48--54",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Quantitative analysis of wild-type and precore mutant hepatitis B virus in carriers

AU - Tsugeno, Hirofumi

AU - Yamada, Gotaro

AU - Kinoshita, Moritoshi

AU - Shimomura, Hiroyuki

AU - Iwasaki, Yoshiaki

AU - Tsuji, Takao

PY - 2002/5/1

Y1 - 2002/5/1

N2 - In the present study, we have analyzed the amount of precore wild-type hepatitis B virus (HBV) (wild-type) and precore mutant HBV (nt 1896: G → A) (precore mutant) of HBV carriers; 31 asymptomatic healthy carriers (ASC) and 28 patients with chronic hepatitis (CH). Wild-type and precore mutant were quantified using sensitive and specific quantification methods: competitive wild-type-sequence-specific assay and competitive mutation-site-specific assay with different sets of specific primers and internal controls. Median serum levels of wild-type and precore mutant were 9.60 and 8.60 log copies/ml (median percentages of precore mutant in total HBV-DNA: 11.7%) in HBeAg(+) ASC, 8.48 and 8.00 (33.3%) in HBeAg(+) CH, and 6.30 and 6.85 (84.71%) in anti-HBe(+) CH, respectively, showing higher levels of the relative amount of precore mutant to wild-type along with HBeAg/anti-HBe status. Only precore mutant, but not wild-type was detected in anti-HBe(+) ASC. Although median percentages of precore mutant at the anti-HBe(+) ASC and CH stages were much higher than those at the HBeAg(+) ASC and CH stages, a substantial amount of precore mutant was found even at the HBeAg(+) stages. Existence of a substantial amount of precore mutant even in HBeAg(+) ASC suggests that the occurrence of precore mutant is not always closely associated with seroconversion from HBeAg to anti-HBe.

AB - In the present study, we have analyzed the amount of precore wild-type hepatitis B virus (HBV) (wild-type) and precore mutant HBV (nt 1896: G → A) (precore mutant) of HBV carriers; 31 asymptomatic healthy carriers (ASC) and 28 patients with chronic hepatitis (CH). Wild-type and precore mutant were quantified using sensitive and specific quantification methods: competitive wild-type-sequence-specific assay and competitive mutation-site-specific assay with different sets of specific primers and internal controls. Median serum levels of wild-type and precore mutant were 9.60 and 8.60 log copies/ml (median percentages of precore mutant in total HBV-DNA: 11.7%) in HBeAg(+) ASC, 8.48 and 8.00 (33.3%) in HBeAg(+) CH, and 6.30 and 6.85 (84.71%) in anti-HBe(+) CH, respectively, showing higher levels of the relative amount of precore mutant to wild-type along with HBeAg/anti-HBe status. Only precore mutant, but not wild-type was detected in anti-HBe(+) ASC. Although median percentages of precore mutant at the anti-HBe(+) ASC and CH stages were much higher than those at the HBeAg(+) ASC and CH stages, a substantial amount of precore mutant was found even at the HBeAg(+) stages. Existence of a substantial amount of precore mutant even in HBeAg(+) ASC suggests that the occurrence of precore mutant is not always closely associated with seroconversion from HBeAg to anti-HBe.

KW - Asymptomatic healthy carrier

KW - Chronic hepatitis B

KW - Competitive mutation-site-specific assay

KW - Competitive wild-type-sequence-specific assay

KW - Polymerase chain reaction

UR - http://www.scopus.com/inward/record.url?scp=0036590556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036590556&partnerID=8YFLogxK

U2 - 10.1016/S1386-6346(01)00156-5

DO - 10.1016/S1386-6346(01)00156-5

M3 - Article

VL - 23

SP - 48

EP - 54

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 1

ER -